April 2, 2009 - A device implanted in the heart using minimally invasive techniques may replace the most widely prescribed drug for stroke prevention in patients with nonvalvular atrial fibrillation, according to research presented during the i2 Summit at the American College of Cardiology’s 58th annual scientific session in Orlando earlier this week.

April 2, 2009 - New findings from a landmark investigational study demonstrated that, for patients with atrial fibrillation who were at increased risk for stroke and could not take an oral anticoagulant (OAC) medication, taking Plavix (clopidogrel bisulfate) in addition to aspirin significantly reduced major vascular events by 11 percent over aspirin alone, at a median of 3.6 years of follow-up (6

April 2, 2009 - The American College of Cardiology Foundation (ACCF) and the Heart Rhythm Society (HRS) are collaborating to deliver free, unlimited access to Cardiosource’s Arrhythmias and Atrial Fibrillation (AF) Clinical Collections containing relevant, up-to-date information for cardiology professionals.

April 2, 2009 — Abbott yesterday announced the initiation of the MOBILITY clinical trial to study the safety and efficacy of the Absolute Pro Peripheral Self-Expanding Stent System in patients with iliac artery disease.

April 2, 2009 - Vasomedical Inc. this week conducted two presentations on the beneficial effects of EECP external counterpulsation therapy at the 58th Annual Scientific Session of the American College of Cardiology (ACC) in Orlando.

April 2, 2009 - The 24-month findings from the REVERSE (Resynchronization Reverse Remodeling in Systolic Left Ventricular Dysfunction) trial, sponsored by Medtronic Inc.

April 2, 2009 - Researchers from the University of Massachusetts Memorial Medical Center's division of vascular and endovascular surgery, examined the national frequency, predictors, outcomes and the effect of institutional volume metrics in cases where endovascular aortic repair (EVAR) was used to repair ruptured abdominal aortic aneurysms (RAAAs) between 2001 and 2006.

April 2, 2009 - TCA Cellular Therapy’s Medical Director Gabriel Lasala, M.D. presented preliminary results of an adult stem cell treatment for severe limb ischemia Sunday at the American College of Cardiology’s first annual i2 Summit.

April 2, 2009 – Invatec received 510(k) clearance from the FDA to market its Amphirion Deep 150 mm Long PTA Balloon and Tapered 210 mm Long PTA Balloon in U.S. The Amphirion Deep Long Balloons join the preexisting Amphirion Deep family of dedicated below the knee (BTK) PTA catheters, which are specifically designed to reach, access and treat arteries below the knee.


As a member of the media, people always ask me what I think the big trends are at the shows I attend. At the Radiological Society of North America (RSNA) imaging conference in December the economy was not the big discussion in sessions or in vendor booths, but it seemed to be the only thing I overheard in hundreds of conversations as I walked through the halls.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now